XML 59 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Information
12 Months Ended
Dec. 31, 2017
Segment Information [Abstract]  
Segment Information [Text Block]

Note 22 Segment Information

See Note 1 for a description of our reporting segments.

In the Company’s segment disclosures, we present “operating revenues,” defined as total revenues excluding realized investment results. The Company excludes realized investment results from this measure because its portfolio managers may sell investments based on factors largely unrelated to the underlying business purposes of each segment. As a result, gains or losses created in this process may not be indicative of past or future underlying performance of the business.

The Company uses “adjusted income from operations” as its principal financial measure of segment operating performance because management believes it best reflects the underlying results of business operations and permits analysis of trends in underlying revenue, expenses and profitability. Adjusted income from operations is defined as shareholders’ net income excluding after-tax realized investment gains and losses, net amortization of other acquired intangible assets and special items. Income or expense amounts are excluded from adjusted income from operations for the following reasons:

  • Realized investment results are excluded because, as noted above, our portfolio managers may sell investments based on factors largely unrelated to the underlying business purposes of each segment.
  • Net amortization of other intangible assets is excluded because it relates to costs incurred for acquisitions and, as a result, it does not relate to the core performance of the Company’s business operations. In 2015, the amortization amount was net of a bargain purchase gain on an acquisition.
  • Special items, if any, are excluded because management believes they are not representative of the underlying results of operations. This is generally because the nature and size of these matters are not indicative of our ongoing business operations. Additional details about these items that provide further context as to why they are not considered indicative of ongoing business operations may be found in the footnotes referenced in the table below.

The following table presents the special items recorded by the Company for the years ended December 31, 2017, 2016 and 2015.

(In millions)
Description of Special Item and Financial Statement Line Item(s)After-taxBefore-tax
Year ended December 31, 2017
Charges associated with U.S. tax reform
- Other operating expenses (see Note 20 for details)$(36)$(56)
- Tax expense (see Note 20 for details)232-
Total charges associated with U.S. tax reform$196$(56)
Debt extinguishment costs (Other operating expenses, see Note 5 for details)$209$321
Long-term care guaranty fund assessment (Other operating expenses, see Note 21(D) for details)$83$129
Transaction-related costs (Other operating expenses, see Note 3 for details)$33$126
Year ended December 31, 2016
Transaction-related costs (Other operating expenses, see Note 3 for details)$147$166
Risk corridor allowance (Other operating expenses, see page ##EndofNotesPage in this Note for details)$80$124
Charges associated with litigation matters (Other operating expenses, see Note 21(E) for a discussion of litigation charges)$25$40
Year ended December 31, 2015
Debt extinguishment costs (Other operating expenses, see Note 5 for details)$65$100
Transaction-related costs (Other operating expenses, see Note 3 for details)$57$66

Summarized segment financial information for the years ended December 31, was as follows:

(In millions)Global Health CareGlobal Supplemental BenefitsGroup Disability and LifeOther OperationsCorporateTotal
2017
Premiums$24,538 $ 3,684 $ 3,985 $ 112 $ (12) $ 32,307
Fees and other revenues (1)4,7226610610(37)4,867
Net investment income378122350346301,226
Mail order pharmacy revenues2,979----2,979
Total operating revenues32,6173,8724,441468(19)41,379
Net realized investment gains (losses)1363274(5)-237
Total revenues32,7533,9044,515463(19)41,616
Depreciation and amortization477543014566
Total benefits and expenses29,4403,4074,04431680338,010
Income (loss) before income taxes3,313497471147(822)3,606
Income taxes (benefits) and net loss attributable to noncontrolling interests1,031195113222(192)1,369
Shareholders' net income (loss) by segment2,282302358(75)(630)2,237
After-tax adjustments to reconcile to adjusted income from operations
Net realized investment (gains) losses(88)(24)(49)41(156)
Amortization of other acquired intangible assets, net4818---66
Special items
U.S. tax reform(137)73(39)138161196
Debt extinguishment costs----209209
Long-term care guaranty fund assessment 68-15--83
Transaction-related costs----3333
Adjusted income (loss) from operations$2,173$369$285$67$(226)$2,668
(In millions)Global Health CareGlobal Supplemental BenefitsGroup Disability and LifeOther OperationsCorporateTotal
2016
Premiums$23,295$3,226$4,002$103$-$30,626
Fees and other revenues (1)4,623499811(21)4,760
Net investment income315110343358211,147
Mail order pharmacy revenues2,966----2,966
Total operating revenues31,1993,3854,443472-39,499
Net realized investment gains119(5)59(5)1169
Total revenues31,3183,3804,502467139,668
Depreciation and amortization526542811610
Total benefits and expenses28,4673,0524,27336952836,689
Income (loss) before taxes2,85132822998(527)2,979
Income taxes (benefits) and net loss attributable to noncontrolling interests1,100606530(143)1,112
Shareholders' net income (loss) by segment1,75126816468(384)1,867
After-tax adjustments to reconcile to adjusted income from operations
Net realized investment (gains)(78)6(39)2-(109)
Amortization of other acquired intangible assets, net7420---94
Special items
Transaction-related costs----147147
Risk corridor allowance80----80
Charges associated with litigation matters25----25
Adjusted income (loss) from operations$1,852 $ 294 $ 125 $ 70 $ (237) $ 2,104
(1) Includes the Company's share of the earnings of its joint ventures in China and India in the Global Supplemental Benefits segment.
(In millions)Global Health CareGlobal Supplemental BenefitsGroup Disability and LifeOther OperationsCorporateTotal
2015
Premiums$22,696$3,000$3,843$103$-$29,642
Fees and other revenues (1)4,357469113(19)4,488
Net investment income34010333736941,153
Mail order pharmacy revenues2,536----2,536
Total operating revenues29,9293,1494,271485(15)37,819
Net realized investment gains43-59-57
Total revenues29,9723,1494,276494(15)37,876
Depreciation and amortization526312611585
Total benefits and expenses27,0282,8493,79637450234,549
Income (loss) before taxes2,944300480120(517)3,327
Income taxes (benefits) and net income attributable to noncontrolling interests1,1503315240(142)1,233
Shareholders' net income (loss) by segment1,79426732880(375)2,094
After-tax adjustments to reconcile to adjusted income from operations
Net realized investment (gains)(30)(1)(4)(5)-(40)
Amortization of other acquired intangible assets, net (2)84(4)---80
Special items
Debt extinguishment costs----6565
Transaction-related costs----5757
Adjusted income (loss) from operations$1,848$262$324$75$(253)$2,256
(1) Includes the Company's share of the earnings of its joint ventures in China and India in the Global Supplemental Benefits segment.
(2) Includes a $23 million bargain purchase gain for a 2015 acquisition.

Revenue from external customers includes premiums, fees and other revenues and mail order pharmacy revenues. The following table presents these revenues by product type for the years ended December 31:

(In millions)201720162015
Global Health Care premiums by product:
Guaranteed cost$6,245$4,610$4,761
Experience-rated2,7412,3832,329
Stop loss3,4833,0822,701
International health care1,9341,8591,834
Dental1,7911,5861,392
Medicare5,5346,6216,142
Medicaid1,0611,1461,102
Medicare Part D7641,1221,589
Other985886846
Total premiums24,53823,29522,696
Fees4,5034,3684,107
Total Global Health Care premiums and fees29,04127,66326,803
Disability2,0912,0451,899
Life, Accident and Supplemental Health5,7045,3005,054
Mail order pharmacy 2,9792,9662,536
Other338378374
Total$40,153$38,352$36,666

Foreign and U.S. revenues from external customers for the three years ended December 31 are shown below. The Company’s foreign revenues are generated by its foreign operating entities. In the periods shown, no foreign country contributed more than 5% of consolidated revenues from external customers.

(In millions)201720162015
United States $ 36,128 $ 34,672 $ 33,185
South Korea1,8921,6661,521
All other foreign countries2,1332,0141,960
Total$40,153$38,352$36,666

The Company had net receivables from CMS of $0.5 billion as of December 31, 2017 and $0.6 billion as of December 31, 2016. These amounts were included in premiums, accounts and notes receivable and reinsurance recoverables. As a percentage of consolidated revenues, premiums and fees from CMS were 17% in 2017, 20% in 2016 and 21% in 2015. These amounts were reported in the Global Health Care segment.

In 2016, the Company recorded an allowance for the balance of its risk corridor receivable from CMS of $124 million based on court decisions and the large risk corridor program deficit. As of December 31, 2017, the Company continues to hold an allowance for the balance of its risk corridor receivable of $109 million based on the current status of court decisions. However, the Company continues to believe that the government has a binding obligation to satisfy the risk corridor receivable.